Handelsbanken Fonder’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Hold |
35,200
| – | – | ﹤0.01% | 1328 |
|
|
2025
Q1 | $307K | Hold |
35,200
| – | – | ﹤0.01% | 1401 |
|
|
2024
Q4 | $505K | Buy |
35,200
+7,000
| +25% | +$100K | ﹤0.01% | 1284 |
|
|
2024
Q3 | $637K | Buy |
28,200
+4,100
| +17% | +$92.6K | ﹤0.01% | 1137 |
|
|
2024
Q2 | $469K | Buy |
24,100
+4,600
| +24% | +$89.5K | ﹤0.01% | 1186 |
|
|
2024
Q1 | $732K | Buy |
+19,500
| New | +$732K | ﹤0.01% | 983 |
|
|
2023
Q4 | – | Sell |
-14,900
| Closed | -$615K | – | 1605 |
|
|
2023
Q3 | $615K | Hold |
14,900
| – | – | ﹤0.01% | 948 |
|
|
2023
Q2 | $832K | Buy |
14,900
+600
| +4% | +$33.5K | ﹤0.01% | 816 |
|
|
2023
Q1 | $798K | Hold |
14,300
| – | – | ﹤0.01% | 782 |
|
|
2022
Q4 | $521K | Hold |
14,300
| – | – | ﹤0.01% | 942 |
|
|
2022
Q3 | $407K | Hold |
14,300
| – | – | ﹤0.01% | 1083 |
|
|
2022
Q2 | $647K | Buy |
14,300
+1,218
| +9% | +$55.1K | ﹤0.01% | 874 |
|
|
2022
Q1 | $995K | Buy |
13,082
+900
| +7% | +$68.5K | 0.01% | 803 |
|
|
2021
Q4 | $1.82M | Buy |
12,182
+4,698
| +63% | +$700K | 0.01% | 647 |
|
|
2021
Q3 | $1.09M | Hold |
7,484
| – | – | 0.01% | 858 |
|
|
2021
Q2 | $1.47M | Sell |
7,484
-5,216
| -41% | -$1.02M | 0.01% | 731 |
|
|
2021
Q1 | $2.3M | Sell |
12,700
-1,000
| -7% | -$181K | 0.01% | 585 |
|
|
2020
Q4 | $1.94M | Buy |
+13,700
| New | +$1.94M | 0.01% | 611 |
|